An important news for patent professionals – starting August 1, 2024, the Jan Vishwas (Amendment of Provisions) Act, 2023 is rolling out some major updates
What is the Patent Agent Exam? The Indian Patent Agent Exam is an assessment conducted by the Indian Patent Office every year to test the
Is Merck ready to face the looming patent cliff? Impact of Inflation Reduction Act (IRA) on Keytruda Inflation Reduction Act (IRA) was passed in 2022
The US FDA approval of Fresenius Kabi’s Tyenne®, the first Tocilizumab biosimilar with both intravenous and subcutaneous formulations, is a breakthrough in bringing high-quality, affordable,
Patent linkage system serves as a crucial tool in the pharmaceutical industry, strategically aligning the approval process of generic drugs with the patent status of
Rivaroxaban, marketed under the brand name Xarelto®, has emerged as a pivotal therapeutic option for various cardiovascular conditions, revolutionizing the landscape of anticoagulant therapy. Its
